Search the Blog

Love what you do and it doesn't feel like work

My name is Intan Schrader and I am co-medical director of the Hereditary Cancer Program with Sophie Sun. I am a medical geneticist, specializing in cancer genetics.  

It was during medical school that I took a serious interest in cancer genetics. After receiving my medical degree from the University of Melbourne, I completed my residency in Medical Genetics at the University of...

First "clinical trial" in Grade 6 for this doctor

I am a medical oncologist and co-medical director of the Hereditary Cancer Program, with Intan Schrader.

I grew up in Toronto, and first became interested in science in grade six.  For my science project that year, I bought samples of acne cream and asked some older (pimply) kids to use and rate the effectiveness of the creams. In retrospect, this was my first randomized phase 2...

The promising future of lung cancer research

Detecting and treating lung cancer early not only offers the best chance of cure, but decreases the symptoms and burden associated with advanced disease. While there is good scientific evidence to show early detection using low-dose CT scans can decrease lung cancer death rate by as much as 20 percent, additional research remains to be done.

More than 50 percent of the lung cancer...

Making a Difference

BC Cancer Foundation donors provide crucial support for clinical care and research to improve the outcome of lung cancer patients. For example, through the generous support of donors, we were able to renovate the Endoscopy Suite at the BC Cancer Agency’s Vancouver Centre to install a sophisticated image management system, and acquire the latest endoscopic ultrasound equipment and different...

Pioneering path in lung cancer research

I grew up in Hong Kong, and came to Canada when I was 17 to do my undergrad and medical school education at the University of Toronto. After graduation, I came to Vancouver to do my residency training in Internal Medicine and Respiratory Medicine at UBC and then post-fellowship training at the Massachusetts General Hospital, in Boston and the National Cancer Center Hospital in Tokyo. I met my...

Introducing October Guest Blogger: Dr. Stephen Lam

I am delighted to introduce Dr. Stephen Lam as this month’s guest blogger.

Dr. Lam is the chair of the Provincial Lung Tumour Group, and directs the MDS-Rix Early Lung Cancer Detection and Translational Research Program at the BC Cancer Agency. His research interest is in early detection, chemoprevention and endoscopic therapy of lung cancer.

He has received numerous awards for...

Investing in people's lives

Philanthropy and research is truly a partnership. We can have a lab full of talented and passionate researchers, but if we don’t have the dollars to fund the research, then the leading-edge discoveries that the BC Cancer Agency has become renowned for wouldn’t happen. There are lots of examples, but I will highlight one—OVCARE—BC’s Ovarian Cancer Research Program.


It's about the people for foundation president

I am very pleased to be this month’s guest blogger. I joined the BC Cancer Foundation as its new President and CEO in mid-April and since then I have been so inspired by the many incredible donors who support the BC Cancer Agency’s brilliant and compassionate team of physicians and scientists.

I thought I’d take this opportunity to share a bit about me. I grew up in New Jersey – yes, I...

Leaning on Darwin’s thinking

In previous posts I wrote about matching treatment to the patient’s tumour. Currently, we choose treatments primarily based on what the lymphoma looks like down the microscope.

At this time, we treat all patients who have diffuse large B-cell lymphoma, the most common form of lymphoma, with one chemotherapy recipe called R-CHOP. This works quite well, curing about 60 percent of...


Subscribe to BC Cancer - Vancouver